Value of Pharmaceuticals & Innovation
It is important to foster an environment that sustains and enhances innovation to ensure the continued discovery and development of new medicines that improve patients’ health and their quality of life.
The increasing prevalence of chronic illnesses and conditions, particularly among older Americans, underscores the importance of continued medical innovation aimed at preventing, treating and curing these costly, life threatening diseases. Over the past decade, growing numbers of patients and families have benefited enormously from innovative new medicines that address an ever wider range of acute and chronic diseases.
To encourage these discoveries, it is important to understand the kind of climate and incentives for innovation and how these incentives may be affected by a variety of public policies.
This focus on innovation cuts across all streams of National Pharmaceutical Council-sponsored research. Current research projects, for example, are focused on the impact of comparative effectiveness research on innovation, the impact of specialty medications on health outcomes, and the role of pharmaceuticals in evolving payment and delivery systems.